Song Zuo Qing
Song Zuo Qing — Chief Physician — Thoracic Surgery for Lung Tumors — Tianjin Medical University General Hospital
Specialties
Specializes in the diagnosis and treatment of thoracic tumors, especially minimally invasive thoracoscopic surgery for early lung cancers such as pulmonary ground-glass nodules, GGN, GGO, ground-glass shadows, and small lung nodules; treatment of benign lung diseases such as pneumothorax and pulmonary bullae; single-port thoracoscopic minimally invasive surgery for pulmonary nodules (including solid nodules and subsolid nodules); surgical treatment of mediastinal tumors, particularly single-port thoracoscopic minimally invasive surgery for early thymomas. Also has high proficiency in conservative treatments for lung cancer, such as targeted therapy and immunotherapy.
Education
Graduated from 301 Hospital in 2006 with a master's degree in thoracic surgery, and graduated from Tianjin Medical University in 2011 with a doctoral degree in thoracic surgery.
Professional Experience
Chief physician, doctoral supervisor, currently serving as the Director of the Medical Affairs Department at Tianjin Medical University General Hospital. In 2006, he joined the Thoracic Tumor Surgery Department of Tianjin Medical University General Hospital, engaged in the diagnosis and treatment of lung tumors; he has been working in thoracic surgery for nearly twenty years and was promoted to chief physician in 2019.
Professional Roles
Member of the Lung Cancer Specialist Committee of the Chinese Anti-Cancer Association, Young Standing Committee Member of the Thoracic Surgery Specialist Committee of the Chinese Research Hospital Association, Member of the Translational Medicine Specialist Committee of the Chinese Microcirculation Society, Member of the Health Economics Theory and Policy Committee of China, Member of the Thoracic Surgery Specialist Committee of the Tianjin Medical Association, Expert of the Tianjin Medical Malpractice Appraisal Committee, Young Editorial Board Member of the Chinese Journal of Lung Cancer, Young Editorial Board Member of BMJ Quality & Safety, Member of IASLC (International Association for the Study of Lung Cancer).